CorVel (CRVL) Stock Overview
Provides workers’ compensation, general and auto liability, and hospital bill auditing and payment integrity solutions. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
CRVL Community Fair Values
Create NarrativeSee what 6 others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
CorVel Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$60.62 |
| 52 Week High | US$93.71 |
| 52 Week Low | US$44.83 |
| Beta | 0.95 |
| 1 Month Change | -5.49% |
| 3 Month Change | 9.49% |
| 1 Year Change | -30.83% |
| 3 Year Change | -15.55% |
| 5 Year Change | 18.48% |
| Change since IPO | 17,836.87% |
Recent News & Updates
CorVel: Trying Its Damnedest To Return To Its Formal Glory (Technical Analysis)
Summary CorVel Corporation (CRVL) has faced a significant decline, with shares down 35% since July 2025, driven by tepid growth and industry headwinds. Recent Q4 results showed improvement: 7% revenue and 20% EPS growth, alongside a 56% surge in new bookings, supporting a cautiously optimistic outlook. Long-term technicals remain bearish, with a death cross and oversold indicators; any rallies are viewed as bear-market bounces until proven otherwise. A sustained breakout above the 40-week moving average and new year-to-date highs would be required to confirm an enduring intermediate rally in CRVL. Read the full article on Seeking AlphaCorVel (CRVL) Stock Could Be 40% Below Fair Value After Marketwise Repricing Launch
CorVel’s New Marketwise Repricing Product CorVel (CRVL) has launched Marketwise Repricing, a medical bill repricing product that uses market-based reimbursement data to support more consistent pricing and cost containment across its existing bill review programs. See our latest analysis for CorVel. CorVel’s launch of Marketwise Repricing arrives after a period where short term momentum has softened, with the 30 day share price return down 6.72% and the year to date share price return down...Recent updates
Shareholder Returns
| CRVL | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -1.7% | -3.0% | 2.4% |
| 1Y | -30.8% | 43.5% | 19.6% |
Return vs Industry: CRVL underperformed the US Healthcare industry which returned 45.3% over the past year.
Return vs Market: CRVL underperformed the US Market which returned 17.5% over the past year.
Price Volatility
| CRVL volatility | |
|---|---|
| CRVL Average Weekly Movement | 5.6% |
| Healthcare Industry Average Movement | 7.5% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CRVL has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: CRVL's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 5,239 | Sarah Scott | www.corvel.com |
CorVel Corporation provides workers’ compensation, general and auto liability, and hospital bill auditing and payment integrity solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing; preferred provider management and reimbursement; retrospective utilization, facility claim, and professional review; pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.
CorVel Corporation Fundamentals Summary
| CRVL fundamental statistics | |
|---|---|
| Market cap | US$3.09b |
| Earnings (TTM) | US$110.34m |
| Revenue (TTM) | US$958.53m |
Is CRVL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CRVL income statement (TTM) | |
|---|---|
| Revenue | US$958.53m |
| Cost of Revenue | US$725.66m |
| Gross Profit | US$232.86m |
| Other Expenses | US$122.52m |
| Earnings | US$110.34m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
Aug 05, 2026
| Earnings per share (EPS) | 2.16 |
| Gross Margin | 24.29% |
| Net Profit Margin | 11.51% |
| Debt/Equity Ratio | 0% |
How did CRVL perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/08/04 06:34 |
| End of Day Share Price | 2026/08/03 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2026/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
CorVel Corporation is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.